Clinicopathological Characteristics of Lymphomas of the Digestive Tract

Shahri, Mehsa Bahram; Eslami, Saadat

[Home ] [Archive]

International Journal of Medical Investigation

Main Menu

Home

Journal Information

Articles archive

For Authors

For Reviewers

Registration

Contact us

Site Facilities

Editorial Board

Search in website

Receive site information

Volume 12, Issue 2 (7-2023)

Int J Med Invest 2023, 12(2): 185-192

Back to browse issues page

Clinicopathological Characteristics of Lymphomas of the Digestive Tract

Mehsa Bahram Shahri

, Saadat Eslami ^*

MD, General Pathology, Department of Pathology, Shahid Sadoughi University of Medical Sciences and Health Services, Yazd, Iran

Abstract: (421 Views)

Background: About 40% of lymphomas occur in non-lymph nodes, most of which are in the digestive system. There are few studies on gastrointestinal lymphomas and their survival rate. Therefore, this study deals with the clinicopathological characteristics of gastrointestinal lymphomas in patients referred to the pathology ward of Shahid Sadoughi Hospital of Yazd, Iran, in 2016-2022.
Method: This descriptive-cross-sectional study was conducted on patients with gastrointestinal lymphoma who referred to Shahid Sadoughi Hospital in Yazd, Iran, in 2016-2022. The factors of age, gender, type of lymphoma, and anatomical location were evaluated. The researchers collected the information after receiving the code of ethics by referring to the data archive department of Shahid Sadoughi Hospital in Yazd. The data were analyzed using SPSS software version 16 and Chi-square and Fisher exact statistical tests.
Results: In this study, 29 patients were examined, of whom 51.2% (16) were men, and the average age was 49.3 years. Based on the location of lymphoma, one case (3.4%) was in the rectum, four cases (13.8%) were in the small intestine, four cases (13.8%) were in the colon, and 20 cases (69%) were in the stomach. Diffuse large B cell lymphoma was the most frequent, with a frequency of 18 cases (62.1%), followed by Maltoma, with six cases (20.7%). Abdominal pain, with a frequency of 13 cases (44.8%), followed by weight loss, with a frequency of nine cases (31%), was the most frequent. The frequency distribution of lymphoma types according to gender and anatomical location was insignificant.
Conclusion: Gastrointestinal lymphomas are often B cell phenotypes, most of which are diffuse large cell types. The anatomical location of more than half of the tumors was in the stomach. Primary tumors of the gastrointestinal tract do not have specific clinical symptoms. These patients’ most frequent clinical symptoms were abdominal pain followed by B clinical symptoms (weight loss, weakness, and lethargy).

Keywords: Diffuse Large B Cell Lymphoma, Maltoma, Gastrointestinal Tract

Full-Text [PDF 500 kb] (520 Downloads)

Type of Study: Research | Subject: General

References

1. 1. Willemze R, Jaffe ES, Burg G, Cerroni L, Berti E, Swerdlow SH, et al. WHO-EORTC classification for cutaneous lymphomas. Blood. 2005;105(10):3768-85. 2. d’Amore F, Brincker H, Grønbaek K, Thorling K, Pedersen M, Jensen M, et al. Non-Hodgkin’s lymphoma of the gastrointestinal tract: a population-based analysis of incidence, geographic distribution, clinicopathologic presentation features, and prognosis. Danish Lymphoma Study Group. Journal of clinical oncology. 1994;12(8):1673-84. 3. Howell JM, Auer-Grzesiak I, Zhang J, Andrews CN, Stewart D, Urbanski SJ. Increasing incidence rates, distribution and histological characteristics of primary gastrointestinal non-Hodgkin lymphoma in a North American population. Canadian Journal of Gastroenterology. 2012;26(7:452-6). 4. Song L-N, Cen X-N, Ou J-P, Liang Z-Y, Qiu Z-X, Wang W-S, et al. Clinical and prognostic analysis of 101 cases of primary gastrointestinal non-Hodgkin’s lymphoma. Zhongguo shi yan xue ye xue za zhi. 2013;21(2):387-91. 5. Yin WJ, Wu MJ, Yang HY, Zhu X, Sun WY. [Clinicopathological features and prognostic factors of 216 cases with primary gastrointestinal tract non-Hodgkin’s lymphoma]. Zhonghua Xue Ye Xue Za Zhi. 2013;34(5):377-82. 6. Papaxoinis G, Papageorgiou S, Rontogianni D, Kaloutsi V, Fountzilas G, Pavlidis N, et al. Primary gastrointestinal non-Hodgkin’s lymphoma: a clinicopathologic study of 128 cases in Greece. A Hellenic Cooperative Oncology Group study (HeCOG). Leuk Lymphoma. 2006;47(10):2140-6. 7. Howell JM, Auer-Grzesiak I, Zhang J, Andrews CN, Stewart D, Urbanski SJ. Increasing incidence rates, distribution and histological characteristics of primary gastrointestinal non-Hodgkin lymphoma in a North American population. Can J Gastroenterol. 2012;26(7):452-6. 8. Liu S, Semenciw R, Mao Y. Increasing incidence of non-Hodgkin’s lymphoma in Canada, 1970-1996: age-period-cohort analysis. Hematol Oncol. 2003;21(2):57-66. 9. Gou HF, Zang J, Jiang M, Yang Y, Cao D, Chen XC. Clinical prognostic analysis of 116 patients with primary intestinal non-Hodgkin lymphoma. Med Oncol. 2012;29(1):227-34. 10. Li YY, Hu DZ, Wang YF, Zhao ZG, Cao Z, Zhang YZ, et al. [Clinical Characteristics of 219 Patients with Primary Gastrointestinal Non-Hodgkin’s Lymphoma]. Zhongguo Shi Yan Xue Ye Xue Za Zhi. 2020;28(3):849-54. 11. Saleem R, Chughtai A, Zafar G, Chughtai O, Javeed S, Chughtai AS. Clinicopathological Spectrum of B-Cell Non-Hodgkin Lymphoma in Pakistan Population: A Single-Center Study. Cureus. 2023;15(1):e34298. 12. Juárez-Salcedo LM, Sokol L, Chavez JC, Dalia S. Primary Gastric Lymphoma, Epidemiology, Clinical Diagnosis, and Treatment. Cancer Control. 2018;25(1):1073274818778256. 13. Ramachandran P, Sahni S, Wang JC. De novo CD5+ primary gastrointestinal diffuse large B-cell lymphoma: challenges with treatment and clinical course. Journal of Investigative Medicine High Impact Case Reports. 2019;7:2324709619893546. 14. Erkurt MA, Aydogdu I, Kuku I, Kaya E, Basaran Y. Clinicopathologic characteristics and therapeutic outcomes of primary gastrointestinal non-Hodgkin’s lymphomas: 10 years of experience from a single center in eastern Anatolia. Medical Principles and Practice. 2009;18(5):399-406. 15. Ishikawa E, Nakamura M, Satou A, Shimada K, Nakamura S. Mucosa-Associated lymphoid tissue (MALT) lymphoma in the gastrointestinal tract in the modern era. Cancers. 2022;14(2):446. 16. Wang GB, Xu GL, Luo GY, Shan HB, Li Y, Gao XY, et al. Primary intestinal non-Hodgkin’s lymphoma: a clinicopathologic analysis of 81 patients. World J Gastroenterol. 2011;17(41):462.5-31. 17. Vetro C, Bonanno G, Giulietti G, Romano A, Conticello C, Chiarenza A, et al. Rare gastrointestinal lymphomas: The endoscopic investigation. World J Gastrointest Endosc. 2015;7(10):928-49. 18. Lambrechts C, Van der Wijst E, Bries G, Bogaert J, De Schepper H, Van Hauthem P, et al. Endoscopic diagnosis of a colonic localization of a mantle cell lymphoma. Acta Gastroenterol Belg. 2022;85(4):632-4. 19. Oña-Ortiz FM, Sánchez-Del Monte J, Ramírez-Solís ME, de la Mora-Levy JG, Alonso-Larraga JO, Lino-Silva LS, et al. Mantle cell lymphoma with involvement of the digestive tract. Rev Gastroenterol Mex (Engl Ed). 2019;84(4):434-41. 20. Sabattini E, Bacci F, Sagramoso C, Pileri SA. WHO classification of hematopoietic and lymphoid tissue tumors in 2008: an overview. Pathologica. 2010;102(3):83-7. 21. Koch P, del Valle F, Berdel WE, Willich NA, Reers B, Hiddemann W, et al. Primary gastrointestinal non-Hodgkin’s lymphoma: I. Anatomic and histologic distribution, clinical features, and survival data of 371 patients registered in the German Multicenter Study GIT NHL 01/92. J Clin Oncol. 2001;19(18):3861-73. 22. Wang T, Gui W, Shen Q. Primary gastrointestinal non-Hodgkin’s lymphoma: clinicopathological and prognostic analysis. Med Oncol. 2010;27(3):661-6. 23. Ge Z, Liu Z, Hu X. Anatomic distribution, clinical features, and survival data of 87 cases of primary gastrointestinal lymphoma. World Journal of Surgical Oncology. 2016;14(1):85. 24. Koniaris LG, Drugas G, Katzman PJ, Salloum R. Management of gastrointestinal lymphoma. J Am Coll Surg. 2003;197(1):127-41. 25. Nakamura S, Matsumoto T, Iida M, Yao T, Tsuneyoshi M. Primary gastrointestinal lymphoma in Japan: a clinicopathologic analysis of 455 patients with special reference to its time trends. Cancer. 2003;-2462(10)97. 26. Peng JC, Zhong L, Ran ZH. Primary lymphomas in the gastrointestinal tract. J Dig Dis. 2015;16(4):169-76. 27. Alvarez-Lesmes J, Chapman JR, Cassidy D, Zhou Y, Garcia-Buitrago M, Montgomery EA, et al. Gastrointestinal Tract Lymphomas: A Review of the Most Commonly Encountered Lymphomas. Archives of Pathology & Laboratory Medicine. 2021;145(12):1585-96. 28. Huang J, Jiang W, Xu R, Huang H, Lv Y, Xia Z, et al. Primary gastric non-Hodgkin’s lymphoma in Chinese patients: clinical characteristics and prognostic factors. BMC Cancer. 2010;10(1):358. 29. Hu C, Yi C, Dai X. Clinical study of 31 patients with primary gastric mucosa-associated lymphoid tissue lymphoma. J Gastroenterol Hepatol. 2006;21(4):722-6.

Add your comments about this article

Mendeley

Zotero

RefWorks

Shahri M B, Eslami S. Clinicopathological Characteristics of Lymphomas of the Digestive Tract. Int J Med Invest 2023; 12 (2) :185-192
URL: http://intjmi.com/article-1-1013-en.html

Rights and permissions
	This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.

Volume 12, Issue 2 (7-2023)

Back to browse issues page

Persian site map - English site map - Created in 0.05 seconds with 37 queries by YEKTAWEB 4645